Purchase Order HHSN302201700212P

<p>The National Human Genome Research Institute awarded a purchase order to Emory University for $24,838.00 with an award date of September 26, 2014 and ultimate completion date of September 25, 2015. Performance takes place in Bethesda, Maryland. The purchase order carries firm fixed-price pricing and no set-aside designation. The specific scope of work is not detailed in the source document.</p>

<p>The National Human Genome Research Institute awarded a purchase order to The Johns Hopkins University on June 4, 2019, for $11,734.00. The order carries no set-aside designation. Place of performance is Bethesda, Maryland. The ultimate completion date is December 31, 2019. No further detail on scope or requirements is provided in the source.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Eurofins Genomics LLC for $14,975.00 on December 13, 2016, with a firm fixed price for research studies. Place of performance is Bethesda, Maryland. The order was not set-aside and carries an ultimate completion date of January 11, 2021.</p>

<p>The National Human Genome Research Institute awarded a purchase order to The Washington University for $13,775.00 on September 7, 2018, with firm fixed pricing and ultimate completion September 11, 2018. Place of performance is Bethesda, Maryland. The source does not specify the scope of work or originating solicitation. No small business set-aside applies.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $18,816.00 on August 31, 2018, with ultimate completion on September 28, 2018. Place of performance is Bethesda, Maryland. The order is priced as firm fixed price with no set-aside used. The source does not specify the items or services procured.</p>

<p>The National Human Genome Research Institute awarded a purchase order to University of Massachusetts Medical School for $11,214.00 on February 4, 2019, with completion on February 12, 2019. Place of performance is Bethesda, Maryland. The order carries firm fixed-price pricing under a no-set-aside procurement. Specific scope details are not described in the available source material.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation for $5,712.00 on August 18, 2017, with ultimate completion by September 15, 2017. Place of performance is Bethesda, Maryland. The order is priced firm fixed price with no set-aside designation. Specific deliverables or line items are not detailed in the source.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $4,452.00 on September 15, 2017, for firm fixed price commercial items. Place of performance is Bethesda, Maryland. The order has an ultimate completion date of December 31, 2017. No set-aside was used.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $5,172.00 on August 2, 2017, for completion by September 1, 2017. Place of performance is North Bethesda, Maryland. The order is for firm fixed price commercial items, with no small business set-aside applied.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Chesapeake Mission Critical LLC valued at $13,871.00 on August 25, 2017, with a completion date of September 8, 2017. Work is performed in Bethesda, Maryland. The order is priced on a firm-fixed-price basis with no set-aside applied. Specific requirements are not detailed in the source material.</p>